Literature DB >> 18369072

Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy.

T Oshitari1, S Yamamoto, N Hata, S Roy.   

Abstract

BACKGROUND: Neuronal abnormalities are associated with the pathogenesis of diabetic retinopathy. However, the mechanisms for neuronal cell death in diabetic retinopathy remain unclear. AIM: To determine whether altered expression of Bax, caspase-9 and -3 is associated with degenerative neurons in diabetic retinopathy.
METHODS: Immunohistochemistry was performed on cryosections obtained from five pairs of normal and five pairs of age-matched diabetic human retinas. Diabetic eyes had no proliferative diabetic retinopathy and no histories of photocoagulation or ocular surgery. In this study, Fluoro-Jade B (FJB) was used as a marker for identification of degenerative neurons.
RESULTS: In diabetic retinas, Bax overexpression coexisted with FJB positive signals in the ganglion cell layer (GCL) compared with very low FJB levels in the normal retina. Increased level of the active forms of caspase-9 and -3 expressions coexisted with FJB positive cells in the GCL of diabetic retinas compared with those in normal retinas.
CONCLUSIONS: Upregulation of Bax, caspase-9 and -3 expression was associated with neuronal degeneration in diabetic retinopathy. The mitochondria- and caspase-dependent cell-death pathway may be, in part, associated with neuronal degeneration in diabetic retinas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18369072     DOI: 10.1136/bjo.2007.132308

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  37 in total

Review 1.  Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.

Authors:  Sidra Zafar; Mira Sachdeva; Benjamin J Frankfort; Roomasa Channa
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

2.  Inflammatory cytokine-specific alterations in retinal endothelial cell function.

Authors:  Tammy L Palenski; Christine M Sorenson; Nader Sheibani
Journal:  Microvasc Res       Date:  2013-06-24       Impact factor: 3.514

Review 3.  Current knowledge on diabetic retinopathy from human donor tissues.

Authors:  Jessica H Eisma; Jennifer E Dulle; Patrice E Fort
Journal:  World J Diabetes       Date:  2015-03-15

4.  Novel role of mitochondrial matrix metalloproteinase-2 in the development of diabetic retinopathy.

Authors:  Ghulam Mohammad; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-01       Impact factor: 4.799

Review 5.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

Review 6.  Diabetic retinal neurodegeneration as a form of diabetic retinopathy.

Authors:  Deepak Soni; Pradeep Sagar; Brijesh Takkar
Journal:  Int Ophthalmol       Date:  2021-05-06       Impact factor: 2.031

7.  Curcumin Inhibits Neuronal Loss in the Retina and Elevates Ca²⁺/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Rats.

Authors:  Jun Li; Peipei Wang; Yanxia Zhu; Zhen Chen; Tianyan Shi; Wensheng Lei; Songping Yu
Journal:  J Ocul Pharmacol Ther       Date:  2015-07-24       Impact factor: 2.671

Review 8.  Retinal ganglion cells in diabetes.

Authors:  Timothy S Kern; Alistair J Barber
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

9.  Increased expression of IRE1alpha and stress-related signal transduction proteins in ischemia-reperfusion injured retina.

Authors:  Natsuyo Hata; Toshiyuki Oshitari; Akiko Yokoyama; Yoshinori Mitamura; Shuichi Yamamoto
Journal:  Clin Ophthalmol       Date:  2008-12

10.  Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injury.

Authors:  Kathleen M Schoch; Heather N Evans; Jennifer M Brelsfoard; Sindhu K Madathil; Jiro Takano; Takaomi C Saido; Kathryn E Saatman
Journal:  Exp Neurol       Date:  2012-05-01       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.